Archive: April 2015
Feature Article
Novel Therapeutic Targets in Multiple Myeloma
Francesca Cottini, MD, and Kenneth Anderson, MD
Clinical Advances in Hematology & Oncology April 2015, Volume13, Issue 4 Novel Therapeutic Targets in Multiple Myeloma Francesca Cottini, MD, and Kenneth Anderson, MD Dr Cottini […]
Feature Article
Curative Treatment for Severe Sickle Cell Disease: Allogeneic Transplantation
Benjamin Oshrine, MD, and Julie-An Talano, MD
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Curative Treatment for Severe Sickle Cell Disease: Allogeneic Transplantation Benjamin Oshrine, MD, and […]
Feature Article
Families With Both Hodgkin Lymphoma and Multiple Myeloma in Their Pedigrees
Peter H. Wiernik, MD, Dona Wickramasinghe, MD, and Janice P. Dutcher, MD
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Families With Both Hodgkin Lymphoma and Multiple Myeloma in Their Pedigrees Peter H. […]
Advances in Oncology
Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer Erica L. Mayer, […]
Advances in Oncology
Combination Therapies for Treating Metastatic Melanoma
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Hussein Tawbi, MD, PhD Associate Professor of Medicine, Clinical & Translational Science, University […]
Advances in LLM
New Developments in Richter Syndrome
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 New Developments in Richter Syndrome Nitin Jain, MD, Assistant Professor, Department of Leukemia, […]
The Role of Sorafenib in Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 The Role of Sorafenib in Hepatocellular Carcinoma Pierre Gholam, MD, Associate Professor of […]
Hem/Onc News
FDA News
Kathryn Turner, PhD
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 By Kathryn Turner, PhD FDA Approves Panobinostat for Relapsed Multiple Myeloma Panobinostat […]
Hem/Onc News
Hem/Onc News
Kathryn Turner, PhD
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 By Kathryn Turner, PhD FDA Approves First US Biosimilar The US Food […]
Letter From the Editor
Letter From the Editor
Bruce D. Cheson, MD
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Inside My File Cabinets We finally have emerged from the dungeon, and are […]